Orbis Diagnostics is a next-generation point of care diagnostics company that is transforming personal healthcare. Powered by microfluidic and photonic innovations, Orbis’ automated desktop system has miniaturised medical labs to deliver real-time, actionable test results from a finger-prick of blood. Orbis is working with leaders in the primary healthcare sector to deploy its technology and support time-critical healthcare decision-making at the point of care. The first product on the market is a quantitative Covid-19 antibody test that measures an individual's immune response from vaccination or prior infection. Orbis is developing a comprehensive portfolio of diagnostic solutions that will improve health outcomes by making routine blood testing more convenient and accessible.